Xintōpica® 12 mg antipruritic. control of atopic dermatitis and pruritus associated with allergic dermatitis in dogs.

Xintōpica® 12 mg

Antipruritic. Control of Atopic Dermatitis and Pruritus Associated with Allergic Dermatitis in Dogs.

Canines Soft Chews

Each 2000 mg chewable tablet contains: Oclacitinib (as Oclacitinib maleate) 12 mg, Excipients and flavorings q.s.ad 1 tablet.

Treatment of pruritus associated with allergic dermatitis in dogs, including flea allergies. Treatment of the clinical manifestations of atopic dermatitis in dogs. Temporary relief of pruritus  associated with sarcoptic mange.

Xintōpica® It is administered orally, at 0.4 - 0.6 mg/kg PO every 12 hours for up to 14 days, then 0.4 - 0.6 mg/kg every 24 hours as maintenance therapy.
.

SENASA Registry: F.115.031.N.00010.

This content is informative reference and should not be considered as prescriptions.

You may also be interested

Agrogenta® 11
Agrogenta® 11
Broad-spectrum aminoglycoside
Injectable Solution
Hematofos B12®
Hematofos B12®
Multi-tonic complemented with phosphorous
Injectable Solution
Vetonic® con Nucleótidos
Vetonic® con Nucleótidos
Integral biostimulant, growth promoter. Unique with nucleotides
Oral Solution